OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Jennifer Pritzker Sells 22,500 Shares of Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Jennifer Pritzker sold 22,500 shares of the business’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $23.35, for a total transaction of $525,375.00. Following the completion of the sale, the insider owned 6,504,133 shares in the company, valued at $151,871,505.55. This represents a 0.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

OrthoPediatrics Stock Performance

NASDAQ:KIDS opened at $22.41 on Friday. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $585.13 million, a P/E ratio of -13.34 and a beta of 0.99. The firm has a 50-day moving average price of $21.78 and a two-hundred day moving average price of $18.87. OrthoPediatrics Corp. has a twelve month low of $14.42 and a twelve month high of $26.74.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative net margin of 15.72% and a negative return on equity of 8.10%. The business had revenue of $70.51 million for the quarter, compared to the consensus estimate of $68.21 million. As a group, research analysts expect that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On OrthoPediatrics

Several hedge funds and other institutional investors have recently made changes to their positions in KIDS. Russell Investments Group Ltd. grew its stake in shares of OrthoPediatrics by 433.1% in the third quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock valued at $26,000 after buying an additional 1,139 shares in the last quarter. Legal & General Group Plc bought a new stake in shares of OrthoPediatrics in the 2nd quarter valued at approximately $34,000. Northwestern Mutual Wealth Management Co. lifted its stake in OrthoPediatrics by 5,226.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock worth $46,000 after purchasing an additional 2,561 shares during the last quarter. Caption Management LLC bought a new stake in shares of OrthoPediatrics during the 3rd quarter valued at about $54,000. Finally, BNP Paribas Financial Markets grew its stake in OrthoPediatrics by 60.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on KIDS. Weiss Ratings raised shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. BTIG Research increased their target price on OrthoPediatrics from $24.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, August 20th. Needham & Company LLC lifted their target price on OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Truist Financial set a $22.00 price target on OrthoPediatrics in a research report on Wednesday, August 5th. Finally, TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Nine investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $26.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.